Search Result "Pediatric Multiple Sclerosis (MS)"
Azathioprine in Multiple Sclerosis
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 8 Issue: 9 Year: 2008 Page: 919-926
Author(s): Paolo Invernizz, Maria Donata Benedetti, Sarah Poli, Salvatore Monaco
Recent Gains in Clinical Multiple Sclerosis Research
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11 Issue: 5 Year: 2012 Page: 497-505
Author(s): T. F. Runia,E. D. van Pelt-Gravesteijn,R. Q. Hintzen
Multiple Sclerosis: Pathogenesis and Treatment
Journal: Current Neuropharmacology
Volume: 9 Issue: 3 Year: 2011 Page: 409-416
Author(s): Ingrid Loma, Rock Heyman
Viruses and Multiple Sclerosis
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11 Issue: 5 Year: 2012 Page: 528-544
Author(s): Jussi Oskari Virtanen,Steve Jacobson
Specificities of Children with Multiple Sclerosis and Neuromyelitis Optica
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2018 Page: 16-20
Author(s): Yara D. Fragoso
Pharmacotherapy of Multiple Sclerosis and Treatment Strategies
Ebook: Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Volume: 9 Year: 2021
Author(s): Amany Ragab,Ali Ibrahim,Rania Helal,Ahmed Elsaid,Hossam Younis,Mona Elsherbiny,Takwa Elkhatib
Doi: 10.2174/9781681089041121090009
Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study
Journal: Current Topics in Medicinal Chemistry
Volume: 20 Issue: 26 Year: 2020 Page: 2391-2403
Author(s): Omar Deeb,Maisa Nabulsi
Updates on Pediatric Demyelinating Disorders
Ebook: Common Pediatric Diseases: an Updated Review
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815039658122010011
Intrathecal Rituximab Therapy in Multiple Sclerosis: Review of Evidence Supporting the Need for Future Trials
Journal: Current Drug Targets
Volume: 15 Issue: 13 Year: 2014 Page: 1205-1214
Author(s): Mickael Bonnan,Sylvie Ferrari,Eric Bertandeau,Stephanie Demasles,Elsa Krim,Marie Miquel,Bruno Barroso
Fatty Acid Amides as a New Potential Therapeutic Agent in Multiple Sclerosis
Ebook: Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Volume: 7 Year: 2020
Author(s): Nicola S Orefice
Doi: 10.2174/9789811447525120070003